Exagen Inc.
XGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $75 | $35 | $41 | $186 |
| - Cash | $22 | $36 | $62 | $99 |
| + Debt | $23 | $24 | $36 | $28 |
| Enterprise Value | $76 | $22 | $15 | $114 |
| Revenue | $56 | $53 | $46 | $48 |
| % Growth | 5.9% | 15.3% | -5.7% | – |
| Gross Profit | $33 | $29 | $21 | $28 |
| % Margin | 59.5% | 56.1% | 46.9% | 57.4% |
| EBITDA | -$11 | -$19 | -$44 | -$23 |
| % Margin | -20% | -36.4% | -95.8% | -47.8% |
| Net Income | -$15 | -$24 | -$47 | -$27 |
| % Margin | -27.2% | -45.1% | -104% | -55.6% |
| EPS Diluted | -0.83 | -1.34 | -2.77 | -1.68 |
| % Growth | 38.1% | 51.6% | -64.9% | – |
| Operating Cash Flow | -$13 | -$14 | -$32 | -$20 |
| Capital Expenditures | -$1 | -$1 | -$4 | -$2 |
| Free Cash Flow | -$14 | -$15 | -$36 | -$23 |